OrthoPediatrics (NASDAQ:KIDS) Issues Earnings Results, Beats Expectations By $0.04 EPS

OrthoPediatrics (NASDAQ:KIDS) released its quarterly earnings results on Tuesday. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04, Zacks reports. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. OrthoPediatrics updated its FY 2025 guidance to EPS.

OrthoPediatrics Stock Down 1.1 %

NASDAQ KIDS traded down $0.26 on Tuesday, reaching $22.89. The company had a trading volume of 237,721 shares, compared to its average volume of 318,574. OrthoPediatrics has a 1 year low of $21.02 and a 1 year high of $35.99. The firm has a market capitalization of $554.30 million, a PE ratio of -18.61 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The firm has a 50-day moving average of $24.38 and a 200-day moving average of $25.97.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Needham & Company LLC restated a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research report on Tuesday, January 14th. Truist Financial dropped their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.